Vascular Biogenics Ltd (VBLT)

[Oren1976]

Having more long term survivors in combo is great news. The power of vb111 will be the long term survivors . The company already knows that and made it as a motive they repeat again and again. The long term survivors is due to relatively more complete responders. This data match the mechanism of action. For the immune system gbm is just another cancer they know how to deal. Only for us human gbm is a monster but not to the immune system. My theory of how it's going to look like is from William coley work. U have nothing else to compare it 2 except the ph2 results . It's sad that in 2017 everybody is running to car-t while Coley attitude is being done almost only by vbl